Interference Appeals Not Just For Fed. Circ., Justices Told

Law360, New York (November 16, 2015, 6:44 PM EST) -- Biogen MA Inc. has asked the U.S. Supreme Court to review a Federal Circuit decision giving the appeals court exclusive jurisdiction over appeals of patent interference decisions and barring district courts from hearing them, saying the ruling relies on a "fundamental misreading" of the America Invents Act.

Biogen, which lost an interference proceeding over a multiple sclerosis treatment to the Japanese Foundation for Cancer Research, said in a cert petition filed Nov. 9 that the Federal Circuit's May ruling upholding the Patent Trial and Appeal Board's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.